OpenURL Connection Search

Select item for more details and to access through your institution.

Cardioprotective Properties of Omentin-1 in Type 2 Diabetes: Evidence from Clinical and <i>In Vitro</i> Studies.
Published in:
PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059697
By:
- Greulich, Sabrina;
- Chen, Weena J. Y.;
- Maxhera, Bujar;
- Rijzewijk, Luuk J.;
- van der Meer, Rutger W.;
- Jonker, Jacqueline T.;
- Mueller, Heidi;
- de Wiza, Daniella Herzfeld;
- Floerke, Ralf-Ruediger;
- Smiris, Konstantinos;
- Lamb, Hildo J.;
- de Roos, Albert;
- Bax, Jeroen J.;
- Romijn, Johannes A.;
- Smit, Jan W. A.;
- Akhyari, Payam;
- Lichtenberg, Artur;
- Eckel, Juergen;
- Diamant, Michaela;
- Ouwens, D. Margriet
Publication type:
Article
Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.
Published in:
Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0549-z
By:
- Chen, Weena J. Y.;
- Diamant, Michaela;
- de Boer, Karin;
- Harms, Hendrik J.;
- Robbers, Lourens F. H. J.;
- van Rossum, Albert C.;
- Kramer, Mark H. H.;
- Lammertsma, Adriaan A.;
- Knaapen, Paul
Publication type:
Article
Activin a is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes.
Published in:
Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-150
By:
- Chen, Weena J. Y.;
- Greulich, Sabrina;
- van der Meer, Rutger W.;
- Rijzewijk, Luuk J.;
- Lamb, Hildo J.;
- de Roos, Albert;
- Smit, Johannes W. A.;
- Romijn, Johannes A.;
- Ruige, Johannes B.;
- Lammertsma, Adriaan A.;
- Lubberink, Mark;
- Diamant, Michaela;
- Ouwens, D. Margriet
Publication type:
Article

Found: 3

Cardioprotective Properties of Omentin-1 in Type 2 Diabetes: Evidence from Clinical and <i>In Vitro</i> Studies.

Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.

Activin a is associated with impaired myocardial glucose metabolism and left ventricular remodeling in patients with uncomplicated type 2 diabetes.